Jun Wei Selected Research

nucleoside diphosphate kinase 2

10/2021

Requirement of transcription factor NME2 for the maintenance of the stemness of gastric cancer stem-like cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Wei Research Topics

Disease

92	Neoplasms (Cancer) 01/2022 - 08/2004
27	Glioma (Gliomas) 01/2022 - 02/2009
27	Fibrosis (Cirrhosis) 01/2021 - 09/2008
24	Schizophrenia (Dementia Praecox) 10/2019 - 05/2003
20	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2009
16	Systemic Scleroderma (Systemic Sclerosis) 02/2020 - 11/2010
15	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2011
12	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2008
11	Infections 06/2021 - 02/2007
10	Wounds and Injuries (Trauma) 01/2022 - 02/2008
10	Carcinogenesis 06/2019 - 12/2008
9	Melanoma (Melanoma, Malignant) 05/2019 - 09/2008
8	Inflammation (Inflammations) 01/2022 - 11/2010
8	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2011
7	Stomach Neoplasms (Stomach Cancer) 08/2022 - 03/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2014
6	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 05/2010
5	Pneumonia (Pneumonitis) 01/2022 - 05/2015
5	Hypoxia (Hypoxemia) 01/2019 - 01/2011
5	Leukemia 03/2013 - 06/2005
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 04/2014
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2014
4	Lung Diseases (Lung Disease) 01/2018 - 08/2013
4	Lymphoma (Lymphomas) 12/2017 - 04/2009
4	Colonic Neoplasms (Colon Cancer) 09/2016 - 07/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 12/2010 - 07/2009
3	Alzheimer Disease (Alzheimer's Disease) 08/2022 - 11/2010
3	Ischemic Stroke 01/2022 - 03/2011
3	Pain (Aches) 01/2022 - 07/2013
3	Adenocarcinoma of Lung 01/2022 - 01/2016
3	Disease Progression 01/2022 - 04/2002
3	COVID-19 06/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 05/2017
3	Rheumatoid Arthritis 01/2021 - 01/2017
3	Brain Neoplasms (Brain Tumor) 01/2021 - 07/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 10/2012
3	Atherosclerosis 12/2018 - 10/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2017 - 11/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2015 - 06/2012
3	Pulmonary Embolism 08/2013 - 12/2007
2	Tuberculosis (Tuberculoses) 05/2022 - 02/2007

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 07/2022 - 03/2002
21	AntibodiesIBA 07/2022 - 04/2002
21	AntigensIBA 05/2022 - 04/2002
20	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2011
17	Biomarkers (Surrogate Marker)IBA 08/2022 - 05/2012
17	Immunoglobulin G (IgG)IBA 10/2019 - 01/2011
15	CytokinesIBA 07/2018 - 05/2003
13	Peptides (Polypeptides)IBA 10/2019 - 03/2014
12	EnzymesIBA 01/2021 - 06/2013
11	Therapeutic UsesIBA 01/2022 - 07/2013
9	Biological ProductsIBA 01/2021 - 01/2009
9	Bleomycin (Blenoxane)FDA LinkGeneric 02/2020 - 06/2011
9	Pharmaceutical PreparationsIBA 01/2020 - 07/2009
9	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 03/2011
9	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2016 - 12/2008
8	AutoantibodiesIBA 10/2018 - 10/2012
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2002
7	ImmunosorbentsIBA 12/2020 - 06/2013
6	WP1066IBA 01/2022 - 09/2008
6	CollagenIBA 01/2021 - 09/2008
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2014 - 11/2010
5	Transcription Factors (Transcription Factor)IBA 10/2021 - 05/2011
5	RetinoidsIBA 06/2020 - 01/2015
5	CateninsIBA 01/2020 - 11/2011
5	InterleukinsIBA 01/2019 - 05/2011
5	LigandsIBA 03/2018 - 11/2010
5	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017 - 03/2011
5	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 06/2015 - 05/2010
4	LipidsIBA 01/2022 - 07/2016
4	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2016
4	Interleukin-6 (Interleukin 6)IBA 02/2020 - 05/2014
4	AdiponectinIBA 01/2017 - 05/2012
4	Transforming Growth Factor beta (TGF-beta)IBA 08/2014 - 09/2008
4	apogossypolIBA 05/2011 - 04/2009
3	Amyloid (Amyloid Fibrils)IBA 08/2022 - 01/2017
3	AcidsIBA 05/2022 - 02/2014
3	OsteopontinIBA 01/2022 - 01/2019
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 02/2007
3	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2017
3	AntioxidantsIBA 10/2021 - 01/2018
3	Serum AlbuminIBA 01/2021 - 03/2017
3	IntegrinsIBA 01/2021 - 10/2011
3	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 01/2016
3	GliadinIBA 01/2019 - 04/2009
3	ApolipoproteinsIBA 12/2018 - 04/2013
3	oxidized low density lipoproteinIBA 12/2018 - 01/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2018 - 12/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 09/2017
3	Annexin A1IBA 01/2017 - 07/2013
3	CaspasesIBA 11/2016 - 06/2015
3	Immunoglobulin A (IgA)IBA 12/2015 - 05/2012
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 08/2013 - 12/2007
2	CortactinIBA 08/2022 - 03/2014
2	tau Proteins (tau Protein)IBA 08/2022 - 01/2017
2	Coloring Agents (Dyes)IBA 05/2022 - 03/2016

Therapy/Procedure

57	Therapeutics 08/2022 - 09/2008
9	Immunotherapy 01/2021 - 02/2009
9	Drug Therapy (Chemotherapy) 04/2017 - 02/2009
6	Radiotherapy 01/2022 - 02/2009